Navigation Links
The state of global biotech: An Ernst & Young perspective

One of the things I always like about the annual BIO International Conference is that the accounting firm of Ernst & Young always releases at this event its latest report on the state of the biotech industry called: Beyond Borders: Global Biotechnology Industry ......

Full article >>> > +33% Net Loss $5.4 $4.0 +35%

Source: Ernst & Young: Beyond Borders: the Global Biotechnology Report 2007

Interestingly, if the biotech industry had kept R&D flat during 2006, it would have made money. Instead, it is an industry looking to embrace risk rather than avoid it, so R&D expenses actually grew 33 percen......

Full article >>> 76% $22.8 82% Europe $11.5 16% $3.6 13% Canada $3.2 4% $.9 3% Asia-Pacific $3.3 4% $.4 2%

Source: E&Y:Beyond Borders

While the above is a good indicator that the U.S. role in this vit......

Full article >>> tr> Denmark 1,052 15 1.8% 8 Israel 1,039 16 1.6% 11 Russia 1,019 17 0.2% 19 Finland 893 18 0.5% 18 Korea 841 19 -......

Full article >>> n's share of this financing and grew 38 percent, European biotech financing grew 47 percent and Canadian financing grew 79 percent. So, it was a stellar year for the industry.

As this report has so much good material, I will try to glean further nuggets for my next article. See you soon!

Previous articles by Michael Rosen



Source:wistechnology.com By Michael Rosen 06/05/07


Related biology technology :

1. Web-based reporting credited with states top healthcare ranking
2. Ethics Board site offers welcome contrast to state IT mistakes
3. GOP, Dems split over funding of state technology projects
4. Madison stem cell company gets $1M from state
5. Traveling stem cell show continues state tour
6. Lack of connectivity is real estates hidden time bomb
7. Madison biotech NimbleGen files for IPO; one of states best-funded firms
8. Is the worst over for state technology failures?
9. Tech ideas in state budget will need help from entrepreneurs
10. TomoTherapy files registration statement for IPO
11. Oskar Anderson to succeed Miszewski as head of state technology division
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/10/2020)... ... March 10, 2020 , ... ... firm, is pleased to announce the addition of Carson Dickey to its ... and validation in the biopharmaceutical cold chain. He provides design and validation ...
(Date:3/3/2020)... ... 2020 , ... Ideal Implant Incorporated Founder and CEO, Robert ... the IMCAS Innovation Shark Tank 2020 in Paris, France in January. The international ... science industries that promise to revolutionize medical practices in their fields. , ...
(Date:2/21/2020)... ... February 20, 2020 , ... ... capability to perform complex, efficient and elegant chemistry. Humans have been increasingly ... our own goals. , Through rapidly evolving technologies and strategies for modern ...
(Date:2/19/2020)... MEMPHIS, Tenn. (PRWEB) , ... February 18, 2020 ... ... of orthopedic medical devices, today announced the launch of a new and unified ... desire to tackle the industry’s most complex engineering challenges, as well as an ...
Breaking Biology Technology:
(Date:3/5/2020)... DIEGO (PRWEB) , ... March 05, 2020 , ... ... today announced a strategic partnership agreement with Phoenestra GmbH to accelerate Cytonus’ existing ... company founded in San Diego, California. Phoenestra is a biotech company located in ...
(Date:3/5/2020)... ... March 05, 2020 , ... Diagenode, a leading global provider ... a subsidiary of global genomics leader BGI Group, today announced a co-marketing agreement ... and Asia Pacific. , Under the terms of the non-exclusive agreement, the ...
(Date:3/4/2020)... ... March 04, 2020 , ... ... CEOs to apply to the MedTech IGNITE program’s 2020 IGNITE Cohort. The MedTech ... curriculum to attract and nurture the next generation of medtech founders and entrepreneurs. ...
Breaking Biology News(10 mins):